HK1001372A1 - Patch for external use - Google Patents

Patch for external use

Info

Publication number
HK1001372A1
HK1001372A1 HK97102612A HK97102612A HK1001372A1 HK 1001372 A1 HK1001372 A1 HK 1001372A1 HK 97102612 A HK97102612 A HK 97102612A HK 97102612 A HK97102612 A HK 97102612A HK 1001372 A1 HK1001372 A1 HK 1001372A1
Authority
HK
Hong Kong
Prior art keywords
patch
external use
antiphlogistic
menthol
molecule
Prior art date
Application number
HK97102612A
Other languages
English (en)
Inventor
Hirano Munehiko
Tsuruta Kiyomi
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of HK1001372A1 publication Critical patent/HK1001372A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK97102612A 1994-09-16 1997-12-23 Patch for external use HK1001372A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24881494 1994-09-16
PCT/JP1995/001798 WO1996008245A1 (fr) 1994-09-16 1995-09-11 Pansement a usage externe

Publications (1)

Publication Number Publication Date
HK1001372A1 true HK1001372A1 (en) 1998-06-19

Family

ID=17183812

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97102612A HK1001372A1 (en) 1994-09-16 1997-12-23 Patch for external use

Country Status (14)

Country Link
US (1) US5869087A (pt)
EP (1) EP0781553B1 (pt)
JP (1) JP3238409B2 (pt)
KR (1) KR100191062B1 (pt)
CN (1) CN1081028C (pt)
AT (1) ATE390132T1 (pt)
AU (1) AU685673B2 (pt)
CA (1) CA2200068C (pt)
DE (1) DE69535737T2 (pt)
ES (1) ES2304783T3 (pt)
HK (1) HK1001372A1 (pt)
PT (1) PT781553E (pt)
TW (1) TW416855B (pt)
WO (1) WO1996008245A1 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08319234A (ja) * 1995-05-24 1996-12-03 Yuutoku Yakuhin Kogyo Kk 経皮吸収型消炎鎮痛貼付剤
US6620430B2 (en) * 1996-12-06 2003-09-16 Hisamitsu Pharmaceutical Co., Inc. Plaster containing felbinac
JP3499247B2 (ja) * 1996-12-06 2004-02-23 久光製薬株式会社 フェルビナク含有貼付剤
JPH10167956A (ja) * 1996-12-11 1998-06-23 Hisamitsu Pharmaceut Co Inc セロトニン受容体拮抗薬含有経皮投与製剤
DE19830649C2 (de) * 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
DE69922257T2 (de) 1998-07-29 2005-11-10 Teijin Ltd. Druckempfindliche klebstoffzusammensetzung und feuchtigkeitsdurchlässiges, druckempfindliches klebeband, druckempfindliche, pharmazeutische klebstoffzusammensetzung und herstellung eines druckempfindlichen klebebandes welches diese zusammensetzung enthält
JP4584381B2 (ja) * 1999-07-30 2010-11-17 久光製薬株式会社 フェルビナク含有貼付剤
JP4854163B2 (ja) * 2000-04-18 2012-01-18 久光製薬株式会社 抗炎症剤含有貼付剤
JP4625157B2 (ja) * 2000-04-27 2011-02-02 ニプロパッチ株式会社 インドメタシン貼付剤
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 ４−ビフェニル酢酸含有貼付剤
JP3525876B2 (ja) 2000-08-23 2004-05-10 花王株式会社 水蒸気発生体
WO2002045701A2 (en) * 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
DE10137405A1 (de) * 2001-07-31 2003-02-20 Beiersdorf Ag Verfahren zur kontinuierlichen Herstellung und Beschichtung von Selbstklebemassen auf Basis von SBC mit mindestens einem pharmazeutischen Wirkstoff
US20030118632A1 (en) * 2001-12-26 2003-06-26 Larry Caldwell Methods and compositions for treating carpal tunnel syndrome
EP1477164B1 (en) 2002-02-19 2012-06-06 Hisamitsu Pharmaceutical Co. Inc. Percutaneous absorption type plaster
JP5300169B2 (ja) * 2002-03-29 2013-09-25 小林製薬株式会社 フェニル酢酸誘導体類及びメントール類を含有する消炎鎮痛剤及び消炎鎮痛作用増強方法
US20050191339A1 (en) * 2002-08-08 2005-09-01 Beiersdorf Ag Skin friendly active ingredient plaster based on SBC, containing at least 34 WT.% of a pharmaceutical active ingredient and production thereof
KR101105612B1 (ko) * 2003-03-18 2012-01-18 히사미쓰 세이야꾸 가부시키가이샤 비스테로이드계 소염 진통제 함유 첩부제
TWI341736B (en) * 2003-12-26 2011-05-11 Hisamitsu Pharmaceutical Co Anti-infammatory adhesive preparations
JP4584620B2 (ja) * 2004-04-30 2010-11-24 久光製薬株式会社 消炎鎮痛外用剤
JP4869583B2 (ja) * 2004-11-30 2012-02-08 久光製薬株式会社 角質剥離が少ない貼付剤
EP1872796B1 (en) * 2005-02-25 2011-09-21 Hisamitsu Pharmaceutical Co., Inc. Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent
JP5280678B2 (ja) 2005-02-28 2013-09-04 帝國製薬株式会社 フルルビプロフェン含有外用貼付剤
KR20070110433A (ko) * 2005-03-10 2007-11-16 히사미쓰 세이야꾸 가부시키가이샤 점착제 및 첩부제
US20060263420A1 (en) * 2005-03-10 2006-11-23 Hisamitsu Pharmaceutical Co., Inc. Adhesive and plaster
JP2007015963A (ja) * 2005-07-06 2007-01-25 Hisamitsu Pharmaceut Co Inc 貼付剤
JP5684441B2 (ja) * 2005-12-28 2015-03-11 久光製薬株式会社 インドメタシン含有貼付剤
EP2128123A4 (en) * 2007-01-29 2011-04-20 Medrx Co Ltd NON-STEROIDAL ANTI-INFLAMMATORY SALT AND ORGANIC AMINO COMPOUND AND USE THEREOF
JP5192297B2 (ja) 2007-07-05 2013-05-08 日東電工株式会社 貼付剤および貼付製剤
US20090110656A1 (en) * 2007-10-31 2009-04-30 Lemke Sarah A Skin cooling composition
US20090157153A1 (en) * 2007-12-13 2009-06-18 Sarah Anne Lemke Skin cooling system
JP5410072B2 (ja) * 2008-10-07 2014-02-05 久光製薬株式会社 エステル化抑制剤としての尿素誘導体及び尿素誘導体によるエステル化抑制方法
JP5410071B2 (ja) * 2008-10-07 2014-02-05 久光製薬株式会社 エステル化抑制剤及びエステル化抑制方法
JP5410070B2 (ja) * 2008-10-07 2014-02-05 久光製薬株式会社 エステル化抑制剤としての炭酸金属塩及び炭酸金属塩によるエステル化抑制方法
US8563641B2 (en) * 2009-03-12 2013-10-22 Fina Technology, Inc. Ionomer compositions and methods of making and using same
CN101502499B (zh) * 2009-03-13 2011-07-27 北京化工大学 一种布洛芬经皮释放贴剂及其制备方法
JP5358551B2 (ja) * 2010-12-07 2013-12-04 小林製薬株式会社 フェニル酢酸誘導体類及びメントール類を含有する消炎鎮痛剤及び消炎鎮痛作用増強方法
JP5785411B2 (ja) * 2011-03-24 2015-09-30 リンテック株式会社 経皮吸収型貼付剤キット
CN105960234A (zh) 2014-02-27 2016-09-21 久光制药株式会社 含有酮洛芬的巴布剂
US10813963B2 (en) 2018-09-04 2020-10-27 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
US11376227B2 (en) 2018-09-04 2022-07-05 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
US11235013B2 (en) 2018-09-04 2022-02-01 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
US11229610B2 (en) 2018-09-04 2022-01-25 Babak Ghalili Cannabinoid and menthol gel compositions, patches and methods
US10813889B2 (en) 2018-09-04 2020-10-27 Babak Ghalili Cannabinoid and menthol compositions and methods
US11344495B2 (en) 2018-09-04 2022-05-31 Babak Ghalili Veterinary cannabinoid, menthol and anesthetic compositions and methods
WO2021154979A1 (en) 2020-01-31 2021-08-05 Babak Ghalili Stabilized menthol and other volatile compound compositions and methods
GB2608314A (en) 2020-02-11 2022-12-28 Babak Ghalili Cannabinoid and menthol transdermal delivery systems and methods
WO2021177940A1 (en) * 2020-03-03 2021-09-10 Babak Ghalili Cannabinoid and menthol gel compositions, patches and methods
US12109381B2 (en) 2020-08-26 2024-10-08 Babak Ghalili Cannabinoid and menthol transdermal delivery systems and methods
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis
US20230120384A1 (en) * 2021-10-19 2023-04-20 Heather Sloan Menthol- and magnesium-infused kinesiology tape

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
JPS58129115A (ja) * 1982-01-27 1983-08-02 Nissan Motor Co Ltd 燃焼器
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
JPS5951215A (ja) * 1982-09-14 1984-03-24 Taisho Pharmaceut Co Ltd 粘着性湿布剤
JPS5973516A (ja) * 1982-10-21 1984-04-25 Eisai Co Ltd 抗炎症剤
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4931283A (en) * 1983-12-22 1990-06-05 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
US4740365A (en) * 1984-04-09 1988-04-26 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
AU629671B2 (en) * 1989-08-03 1992-10-08 Hisamitsu Pharmaceutical Co. Inc. Skin cream preparation for external use
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
ES2136093T3 (es) * 1991-11-11 1999-11-16 Hisamitsu Pharmaceutical Co Fomentacion que contiene cetorolac.

Also Published As

Publication number Publication date
TW416855B (en) 2001-01-01
AU685673B2 (en) 1998-01-22
WO1996008245A1 (fr) 1996-03-21
EP0781553A4 (en) 2005-04-27
CN1081028C (zh) 2002-03-20
ES2304783T3 (es) 2008-10-16
KR970705986A (ko) 1997-11-03
AU3400095A (en) 1996-03-29
PT781553E (pt) 2008-04-09
CA2200068C (en) 2005-01-11
EP0781553B1 (en) 2008-03-26
JP3238409B2 (ja) 2001-12-17
CN1158083A (zh) 1997-08-27
ATE390132T1 (de) 2008-04-15
DE69535737D1 (de) 2008-05-08
EP0781553A1 (en) 1997-07-02
US5869087A (en) 1999-02-09
DE69535737T2 (de) 2009-04-09
KR100191062B1 (ko) 1999-06-15
CA2200068A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
HK1001372A1 (en) Patch for external use
CA2203936A1 (en) Boronic ester and acid compounds, synthesis and uses
AU6212094A (en) Anti-stall tip treatment means
EP0690039A3 (en) Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof
AU4124997A (en) Fatty acid treatment
CA2147341A1 (en) Skin treatment composition comprising l-lactic acid and n-acetyl-l-cysteine
AU4026695A (en) Aromatically substituted w-amino-alkanoic acid amides and alkanoic acid diamides
AU5556396A (en) Hydroxamic and carboxylic acids as metalloprotease inhibitor s
IL115318A0 (en) 2, 9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives
AU4257096A (en) Substituted carboxylic acid amides and their use as fungicides
AU4451797A (en) 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
AU2028995A (en) L-lysyl-glycyl-L-histidine and therapeutic agent for wound healing containing the same
HU9503309D0 (en) Carboxylic acid amide benzothiophene-s-oxides
ES2158187T3 (es) Agente de avivaje.
AU3176595A (en) Fatty acid treatment
EP0765857A4 (en) OPTICALLY ACTIVE ALPHA-SUBSTITUTED CARBONIC ACID DERIVATIVE AND A METHOD FOR THE PRODUCTION THEREOF
HU9601167D0 (en) 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
EP0643054A3 (en) Process for the preparation of carbonic acid ester derivatives and intermediates.
IL123213A0 (en) Carboxylic acid derivatives
EP0831095A3 (de) Verfahren zur Herstellung von Diketopyrrolopyrrol-Carbonsäuren, deren Estern und Amiden
AU6354696A (en) Carboxylic acid amide derivatives and their use as pesticides
AU6096396A (en) N,n-disulfonylated aminobenzene carboxylic acids and the use thereof as thrombin inhibitors
ZA961394B (en) Substituted DTPA monoamides of the central carboxylic acid group and their metal complexes.
AU3076295A (en) Heterocyclyl-1-phenyl substituted quinolone carboxylic acids as antiviral agents
ZA958612B (en) Chiral lpha-tertiary caroxylic acid esters

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20150910